Success Metrics

Clinical Success Rate

90.0%

Based on 9 completed trials

Completion Rate

90%(9/10)

Active Trials

3(23%)

Results Posted

67%(6 trials)

Terminated

1(8%)

Phase Distribution

Ph not_applicable

Ph early_phase_1

38%

Ph phase_2

15%

Ph phase_1

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Early Phase 1First-in-human

5(38.5%)

Phase 1Safety & dosage

5(38.5%)

Phase 2Efficacy & side effects

2(15.4%)

N/ANon-phased studies

1(7.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(9)

Terminated(1)

Detailed Status

Completed9

Recruiting3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

90.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 15 (38.5%)

Phase 15 (38.5%)

Phase 22 (15.4%)

N/A1 (7.7%)

Trials by Status

recruiting323%

terminated18%

completed969%

Recent Activity

3 active trials

Showing 5 of 13

recruitingphase_2

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

NCT05783817

recruitingphase_2

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

NCT06721494

recruitingearly_phase_1

Clinical Trials (13)

Showing 13 of 13 trials

NCT05783817Phase 2

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

Recruiting

NCT06721494Phase 2

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

Recruiting

NCT06989853Early Phase 1

Methamphetamine and Troriluzole

Recruiting

NCT04642820Early Phase 1

Drugs Brain and Behavior (DDP)

Completed

NCT04614584Phase 1

Mirtazapine and Methamphetamine Drug-drug Interaction Study

Completed

NCT05379959Early Phase 1

Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function

Completed

NCT05003076Early Phase 1

Brain Function and EEG

Completed

NCT03790618Phase 1

Effect of Stimulant Drugs on Social Perception

Completed

NCT04178993Phase 1

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

Completed

NCT03106571Phase 1

Study of Pomaglumetad and Methamphetamine

Terminated

NCT02058966Early Phase 1

Pilot Study of Entacapone for Methamphetamine Abuse

Completed

NCT02323048Not Applicable

Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans

Completed

NCT01843205Phase 1

Buspirone as a Candidate Medication for Methamphetamine Abuse

Completed

All 13 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 13